Kairos Pharma Ltd.

1.73
-0.04 (-2.26%)
At close: Jan 17, 2025, 3:59 PM
1.73
0.00%
After-hours Jan 17, 2025, 06:30 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a
Operating Income -1.71M -571.00K -1.94M -1.05M
Interest Income n/a n/a n/a n/a
Pretax Income -1.81M -1.05M -2.15M -1.05M
Net Income -1.81M -1.05M -2.15M -1.05M
Selling & General & Admin 1.47M 324.00K 1.66M 1.03M
Research & Development 82.00K 87.00K 183.00K 20.00K
Other Expenses 160.00K 160.00K 98.00K n/a
Operating Expenses 1.71M 571.00K 1.94M 1.05M
Interest Expense 98.00K 479.00K 202.00K 5.41K
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 1.71M 571.00K 1.94M 1.05M
Income Tax n/a n/a n/a n/a
Shares Outstanding (Basic) 10.38M 10.24M 12.84M 11.22M
Shares Outstanding (Diluted) 10.38M 10.24M 12.84M 11.22M
EPS (Basic) -0.17 -0.1 -0.17 -0.09
EPS (Diluted) -0.17 -0.1 -0.17 -0.09
EBITDA -1.55M -431.00K -1.88M -1.05M
Depreciation & Amortization 160.00K 160.00K 98.00K -58